title: Selection bias in clinical trials with antipsychotics.
abstract: Although the selection of patients is known to be a powerful factor affecting the results of clinical trials, little is known about recruitment issues. Many patients with schizophrenia who are screened for a clinical trial of an investigational antipsychotic are ultimately not included in the study. Therefore, the question arises of whether the results obtained by studying a selected group of patients are really representative of the general population of patients with schizophrenia. The authors studied possible reasons for selective sampling in 200 patients who were consecutively admitted to inpatient units of Innsbruck's Department of Psychiatry with a diagnosis of schizophreniform or schizophrenic disorder over a time period of 33 months. Apart from demographic data and a psychopathologic rating (using the Brief Psychiatric Rating Scale), the authors recorded whether or not a patient was included in a phase III study and whether or not those were not included would have theoretically been eligible for such a study. Twenty-seven patients were finally recruited for a clinical trial. These patients were younger, on average, had a more recent onset of illness, and had experienced fewer psychotic episodes in the past. A history of noncompliance with previous treatment and the refusal of consent were the most common reasons for not including theoretically eligible patients in a clinical trial.
authors: Department of Biological Psychiatry, University Clinics Innsbruck, Austria. Birgit.Mader@uibk.ac.at
authors: A
authors: A
authors: Hofer
authors: M
authors: M
authors: Hummer
authors: R
authors: R
authors: Huber
authors: M
authors: M
authors: Kurz
authors: T
authors: T
authors: Walch
authors: W W
authors: WW
authors: Fleischhacker
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D010054:Brief Psychiatric Rating Scale / Q000706:statistics & numerical data*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology; D015983:Selection Bias; D018709:Statistics, Nonparametric
chemical_list: D014150:Antipsychotic Agents